Edition:
United States

People: Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

10.80EUR
28 Apr 2017
Change (% chg)

€-0.10 (-0.96%)
Prev Close
€10.90
Open
€10.90
Day's High
€11.02
Day's Low
€10.70
Volume
89,042
Avg. Vol
161,071
52-wk High
€14.69
52-wk Low
€8.21

Tersago, Dominique 

Ms. Dominique Tersago is Chief Medical Officer of Ablynx NV. since July 2013. She joined the Company in January 2011 to head the Medical group. Prior to joining the Company, she was Director Regulatory Strategy, Europe with Bristol-Myers Squibb International in the therapeutic areas of oncology and virology. She received her Doctorate of Medicine degree from Universiteit Antwerpen, Belgium. She joined the pharmaceutical industry in 1994 with Janssen Research Foundation (Johnson & Johnson) and has held positions in clinical development and regulatory strategy.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --